Under normal conditions the mesenchymal stem/stromal cells from the bone marrow of adults develop into cartilage tissue which then remodels into bone tissue. This is similar to what happens after a fracture, for example.
However, the researchers found they could prevent embryonic cartilage from becoming bone tissue by inhibiting the signaling pathway of a specific protein called Bone Morphogenetic Protein (BMP). By temporarily blocking specific BMP receptors they were able to maintain stable cartilage tissue in the lab and in mice.
“Importantly, we have achieved our insights by mimicking molecular processes occurring during embryonic cartilage formation,” said study leader Ivan Martin.
The findings confirm the importance of the field of “developmental engineering” where natural processes are replicated to control the development of adult stem and progenitor cells. The Basel researchers worked with the Novartis Institutes for Biomedical Research, which produced and supplied the inhibitors. The results were publishedExternal link in the US Proceedings of the National Academy of Sciences (PNAS) journal this Monday.
According to Martin, the “cultivated cartilage” could potentially be used to treat cartilage injuries and degeneration by manufacturing engineered cartilage grafts, combining it with existing procedures, or releasing it directly into joints. Transforming this discovery into clinical use is still a long time away though, he cautions.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Former Vatican auditor cleared of bribery in Zurich trial
This content was published on
The Zurich District Court acquitted a former financial markets supervisor at the Vatican of charges of corruption and bribery.
This content was published on
The President of the Swiss Conference of Bishops wants a national digital register of clergy – in the interest of transparency.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss research team cures arthritis in mice
This content was published on
Up to this point, doctors have used various drugs to slow or stop the progression of the disease. But the therapy developed by ETH Zurich researchers takes the treatment of rheumatoid arthritis in mice to a new level: after receiving the medication, researchers consider the animals to be fully cured. The drug is a biotechnologically…
This content was published on
This new technique was applied on five patients, aged 76 to 88, with severe defects on their nose after skin cancer surgery. One year after the reconstruction, all five patients were satisfied with their ability to breathe as well as with the cosmetic appearance of their nose. None of them reported any side effects. The…
This content was published on
The largest bird in the Alps, the bearded vulture was exterminated in the 19th century and is a vulnerable species today.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.